Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study

oleh: Jorge R. Georgakopoulos, MD, Tina Felfeli, MD, Aaron M. Drucker, MD, ScM, FRCPC, Christine E. Jo, BSc, Vincent Piguet, MD, PhD, FRCP, Jensen Yeung, MD, FRCPC

Format: Article
Diterbitkan: Elsevier 2021-09-01

Deskripsi

Subjek

adverse event; atopic dermatitis; drug survival; dupilumab; efficacy; safety